194 related articles for article (PubMed ID: 24400253)
1. Biomarkers of pediatric brain tumors.
Russell MD; Young AM; Karri SK
Front Pediatr; 2013 Mar; 1():7. PubMed ID: 24400253
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal Fluid biomarkers in pediatric brain tumors: A systematic review.
Lehner KR; Jiang K; Rincon-Torroella J; Perera R; Bettegowda C
Neoplasia; 2023 Jan; 35():100852. PubMed ID: 36516487
[TBL] [Abstract][Full Text] [Related]
3. Pediatric posterior fossa tumors outcomes: Experience in a tertiary care center in the Middle East.
Moussalem C; Ftouni L; Mrad ZA; Amine A; Hamideh D; Baassiri W; Bali B; Najjar M
Clin Neurol Neurosurg; 2020 Oct; 197():106170. PubMed ID: 32861036
[TBL] [Abstract][Full Text] [Related]
4. The Clinical Applications of Liquid Biopsies in Pediatric Brain Tumors: A Systematic Literature Review.
Greuter L; Frank N; Guzman R; Soleman J
Cancers (Basel); 2022 May; 14(11):. PubMed ID: 35681663
[TBL] [Abstract][Full Text] [Related]
5. Proteomic analysis of cerebrospinal fluid from children with central nervous system tumors identifies candidate proteins relating to tumor metastatic spread.
Spreafico F; Bongarzone I; Pizzamiglio S; Magni R; Taverna E; De Bortoli M; Ciniselli CM; Barzanò E; Biassoni V; Luchini A; Liotta LA; Zhou W; Signore M; Verderio P; Massimino M
Oncotarget; 2017 Jul; 8(28):46177-46190. PubMed ID: 28526811
[TBL] [Abstract][Full Text] [Related]
6. Proteomic analyses of CSF aimed at biomarker development for pediatric brain tumors.
Samuel N; Remke M; Rutka JT; Raught B; Malkin D
J Neurooncol; 2014 Jun; 118(2):225-238. PubMed ID: 24771250
[TBL] [Abstract][Full Text] [Related]
7. Utilization of Cerebrospinal Fluid Proteome Analysis in the Diagnosis of Meningioma: A Systematic Review.
Choudhary R; Elabbas A; Vyas A; Osborne D; Chigurupati HD; Abbas LF; Kampa P; M H F; Sarwar H; Alfonso M
Cureus; 2021 Dec; 13(12):e20707. PubMed ID: 34966627
[TBL] [Abstract][Full Text] [Related]
8. Potential biomarkers of childhood brain tumor identified by proteomics of cerebrospinal fluid from extraventricular drainage (EVD).
Bruschi M; Petretto A; Cama A; Pavanello M; Bartolucci M; Morana G; Ramenghi LA; Garré ML; Ghiggeri GM; Panfoli I; Candiano G
Sci Rep; 2021 Jan; 11(1):1818. PubMed ID: 33469081
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor-binding protein-2 concentrations in cerebrospinal fluid and serum of children with malignant solid tumors or acute leukemia.
Müller HL; Oh Y; Lehrnbecher T; Blum WF; Rosenfeld RG
J Clin Endocrinol Metab; 1994 Aug; 79(2):428-34. PubMed ID: 7519190
[TBL] [Abstract][Full Text] [Related]
10. Urinary protein biomarkers for pediatric medulloblastoma.
Hao X; Guo Z; Sun H; Liu X; Zhang Y; Zhang L; Sun W; Tian Y
J Proteomics; 2020 Aug; 225():103832. PubMed ID: 32474013
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid biomarkers for brain tumor detection: clinical roles and current progress.
Xiao F; Lv S; Zong Z; Wu L; Tang X; Kuang W; Zhang P; Li X; Fu J; Xiao M; Wu M; Wu L; Zhu X; Huang K; Guo H
Am J Transl Res; 2020; 12(4):1379-1396. PubMed ID: 32355549
[TBL] [Abstract][Full Text] [Related]
12. Liquid biopsy in pediatric brain tumors.
Tripathy A; John V; Wadden J; Kong S; Sharba S; Koschmann C
Front Genet; 2022; 13():1114762. PubMed ID: 36685825
[TBL] [Abstract][Full Text] [Related]
13. Pediatric Central Nervous System Tumors in Nepal: Retrospective Analysis and Literature Review of Low- and Middle-Income Countries.
Azad TD; Shrestha RK; Vaca S; Niyaf A; Pradhananga A; Sedain G; Sharma MR; Shilpakar SK; Grant GA
World Neurosurg; 2015 Dec; 84(6):1832-7. PubMed ID: 26283488
[TBL] [Abstract][Full Text] [Related]
14. Liquid Biomarkers for Pediatric Brain Tumors: Biological Features, Advantages and Perspectives.
Madlener S; Gojo J
J Pers Med; 2020 Nov; 10(4):. PubMed ID: 33260839
[TBL] [Abstract][Full Text] [Related]
15. Cell-Free miRNAs as Non-Invasive Biomarkers in Brain Tumors.
Beylerli O; Encarnacion Ramirez MJ; Shumadalova A; Ilyasova T; Zemlyanskiy M; Beilerli A; Montemurro N
Diagnostics (Basel); 2023 Sep; 13(18):. PubMed ID: 37761255
[TBL] [Abstract][Full Text] [Related]
16. Insights into pediatric diffuse intrinsic pontine glioma through proteomic analysis of cerebrospinal fluid.
Saratsis AM; Yadavilli S; Magge S; Rood BR; Perez J; Hill DA; Hwang E; Kilburn L; Packer RJ; Nazarian J
Neuro Oncol; 2012 May; 14(5):547-60. PubMed ID: 22492959
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal Fluid MicroRNA Signatures as Diagnostic Biomarkers in Brain Tumors.
Kopkova A; Sana J; Machackova T; Vecera M; Radova L; Trachtova K; Vybihal V; Smrcka M; Kazda T; Slaby O; Fadrus P
Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31614872
[TBL] [Abstract][Full Text] [Related]
18. Pseudocholinesterase activity in cerebrospinal fluid as a biomarker of solid central nervous system tumors in children.
Mikecin L; Krizmaric M; Stepan Giljevic J; Gjurasin M; Kern J; Lenicek Krleza J; Popovic L
Croat Med J; 2013 Oct; 54(5):429-35. PubMed ID: 24170721
[TBL] [Abstract][Full Text] [Related]
19. Using urinary bFGF and TIMP3 levels to predict the presence of juvenile pilocytic astrocytoma and establish a distinct biomarker signature.
Pricola Fehnel K; Duggins-Warf M; Zurakowski D; McKee-Proctor M; Majumder R; Raber M; Han X; Smith ER
J Neurosurg Pediatr; 2016 Oct; 18(4):396-407. PubMed ID: 27314542
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
